These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2792 related articles for article (PubMed ID: 15836891)

  • 21. Pathophysiology of the metabolic syndrome: implications for the cardiometabolic risks associated with type 2 diabetes.
    Leroith D
    Am J Med Sci; 2012 Jan; 343(1):13-6. PubMed ID: 22205060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin resistance and the metabolic syndrome as predictors of cardiovascular risk: where are we now?
    Sattar N
    Minerva Endocrinol; 2005 Sep; 30(3):121-38. PubMed ID: 16208304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease.
    Haffner SM
    Am J Cardiol; 2006 Jan; 97(2A):3A-11A. PubMed ID: 16442931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology.
    Ren J; Kelley RO
    Obesity (Silver Spring); 2009 Jun; 17(6):1114-23. PubMed ID: 19214173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of metabolic risk factors and development of cardiovascular disease and diabetes.
    Haffner SM
    Obesity (Silver Spring); 2006 Jun; 14 Suppl 3():121S-127S. PubMed ID: 16931493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic syndrome: definition and therapeutic implications.
    Prasad H; Ryan DA; Celzo MF; Stapleton D
    Postgrad Med; 2012 Jan; 124(1):21-30. PubMed ID: 22314111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes and the metabolic syndrome--when is it best to intervene to prevent?
    Haffner S
    Atheroscler Suppl; 2006 Apr; 7(1):3-10. PubMed ID: 16504598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Insulin resistance, metabolic syndrome and cardiovascular diseases].
    Zeman M; Zák A; Vecka M; Tvrzická E
    Cas Lek Cesk; 2005; 144 Suppl 1():19-20, 22-6. PubMed ID: 15981981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The metabolic syndrome and type 2 diabetes.
    Poole R; Byrne CD
    Minerva Endocrinol; 2005 Sep; 30(3):139-59. PubMed ID: 16208305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Metabolic syndrome: precursor to diabetes and cardiovascular diseases].
    Arsenault P; Cloutier L; Longpré S
    Perspect Infirm; 2012; 9(3):30-4. PubMed ID: 23451420
    [No Abstract]   [Full Text] [Related]  

  • 31. Obesity and metabolic syndrome as related to cardiovascular disease.
    Nikolopoulou A; Kadoglou NP
    Expert Rev Cardiovasc Ther; 2012 Jul; 10(7):933-9. PubMed ID: 22908926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of appropriate patients for cardiometabolic risk management.
    Peters AL
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S9-16. PubMed ID: 17934394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic syndrome.
    Cho LW
    Singapore Med J; 2011 Nov; 52(11):779-85. PubMed ID: 22173246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of the metabolic syndrome in pediatrics: a blessing and a curse.
    Battista M; Murray RD; Daniels SR
    Semin Pediatr Surg; 2009 Aug; 18(3):136-43. PubMed ID: 19573755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The metabolic syndrome: mechanisms, epidemiology, and clinical implications.
    Postgrad Med; 2003 Dec; 114(6 Suppl Managing Metabolic):17-27. PubMed ID: 19667650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic syndrome a widespread threatening condition; risk factors, diagnostic criteria, therapeutic options, prevention and controversies: an overview.
    Amihăesei IC; Chelaru L
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):896-900. PubMed ID: 25581945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic syndrome: what are the risks for humans?
    Gupta A; Gupta V
    Biosci Trends; 2010 Oct; 4(5):204-12. PubMed ID: 21068471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance.
    Kendall DM; Harmel AP
    Am J Manag Care; 2002 Dec; 8(20 Suppl):S635-53; quiz S654-7. PubMed ID: 12510788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New insights into understanding cardiometabolic risk. Introduction.
    Fonarow GC; Watson KE
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S1-2. PubMed ID: 17934389
    [No Abstract]   [Full Text] [Related]  

  • 40. Recent advances in metabolic syndrome and cardiovascular disease.
    Guize L; Pannier B; Thomas F; Bean K; Jégo B; Benetos A
    Arch Cardiovasc Dis; 2008 Sep; 101(9):577-83. PubMed ID: 19041842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 140.